{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:47:43Z","timestamp":1792216063503,"version":"4.4.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2020.00115","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T05:52:16Z","timestamp":1595915536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33\/sST2"],"prefix":"10.3389","volume":"7","author":[{"given":"Ade M.","family":"Ambari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budhi","family":"Setianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Santoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basuni","family":"Radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bambang","family":"Dwiputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Susilowati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadilla","family":"Tulrahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"Doevendans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jacc.2018.06.063","article-title":"Rheumatic heart disease worldwide: JACC scientific expert panel","volume":"72","author":"Watkins","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis."},{"key":"B3","unstructured":"35Health Statistics and Information Systems|Disease Burden and Mortality Estimates2018"},{"key":"B4","first-page":"246","article-title":"The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa","volume":"96","author":"Mayosi","year":"2006","journal-title":"S Afr Med J."},{"key":"B5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5694\/j.1326-5377.1996.tb122012.x","article-title":"Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory","volume":"164","author":"Carapetis","year":"1996","journal-title":"Med J Aust."},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10875-009-9332-6","article-title":"Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease","volume":"30","author":"Guilherme","year":"2010","journal-title":"J Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"8","author":"Murphy","year":"2015","journal-title":"Fibrogenesis Tissue Repair."},{"key":"B9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCHEARTFAILURE.113.001036","article-title":"Prognostic value of soluble ST2 in the valsartan heart failure trial","volume":"7","author":"Anand","year":"2014","journal-title":"Circ Heart Fail."},{"key":"B11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0083-6729(06)74008-0","article-title":"The newest interleukins: recent additions to the ever-growing cytokine family","volume":"74","author":"Chen","year":"2006","journal-title":"Vitam Horm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac remodelling and RAS inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther Adv Cardiovasc Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fcimb.2014.00140","article-title":"Responses of innate immune cells to group A Streptococcus","volume":"4","author":"Fieber","year":"2014","journal-title":"Front Cell Infect Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1189\/jlb.4MR0617-227RR","article-title":"Group A streptococcal pharyngitis: Immune responses involved in bacterial clearance and GAS-associated immunopathologies","volume":"103","author":"Soderholm","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1005682","DOI":"10.1371\/journal.ppat.1005682","article-title":"Conquering neutrophils","volume":"12","author":"D\u00f6hrmann","year":"2016","journal-title":"PLoS Pathog."},{"key":"B16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1042\/CS20140703","article-title":"Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette- smoke-induced lung inflammation in mice","volume":"129","author":"Bozinovski","year":"2015","journal-title":"Clin Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0168861","DOI":"10.1371\/journal.pone.0168861","article-title":"Co-Activation of Th17 and antibody responses provides efficient protection against mucosal infection by group a streptococcus","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0119727","DOI":"10.1371\/journal.pone.0119727","article-title":"Innate immune response to streptococcus pyogenes depends on the combined activation of TLR13 and TLR2","volume":"10","author":"Fieber","year":"2015","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e101464","DOI":"10.1371\/journal.pone.0101464","article-title":"The innate immune response elicited by Group A Streptococcus is highly variable among clinical isolates and correlates with the emm type","volume":"9","author":"Dinis","year":"2014","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.4049\/jimmunol.1101385","article-title":"Recruited macrophages control dissemination of group A Streptococcus from infected soft tissues","volume":"187","author":"Mishalian","year":"2011","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.chom.2016.02.003","article-title":"Type I Interferon signaling prevents IL-1 b -driven lethal systemic hyperinflammation during invasive bacterial infection of soft tissue article type i interferon signaling prevents IL-1 b -driven lethal systemic hyperinflammation during invasive bacterial infection of soft tissue","volume":"19","author":"Castiglia","year":"2016"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.4049\/jimmunol.171.11.6145","article-title":"Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88","volume":"171","author":"Joosten","year":"2003","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1128\/IAI.01680-07","article-title":"Immune recognition of Streptococcus pyogenes by dendritic cells","volume":"76","author":"Loof","year":"2008","journal-title":"Infect Immun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.4049\/jimmunol.175.6.3862","article-title":"The role of the MHC on resistance to group a streptococci in mice 1","volume":"175","author":"Goldmann","year":"2020"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1004266","article-title":"Host responses to group a streptococcus : cell death and inflammation","volume":"10","author":"Tsatsaronis","year":"2014"},{"key":"B26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1189\/jlb.1003461","article-title":"Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells","volume":"75","author":"Veckman","year":"2004","journal-title":"J Leukoc Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/15476910801897953","article-title":"IL-23\/IL-17 biology and therapeutic considerations","volume":"5","author":"Dong","year":"2008","journal-title":"J Immunotoxicol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"C2","DOI":"10.1016\/j.vaccine.2010.07.022","article-title":"Key concepts in immunology","volume":"28","author":"Moser","year":"2010","journal-title":"Vaccine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0974-2069.79617","article-title":"Genes, autoimmunity and pathogenesis of rheumatic heart disease","volume":"4","author":"Guilherme","year":"2011","journal-title":"Ann Pediatr Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/318076","article-title":"Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium","volume":"183","author":"Roberts","year":"2001","journal-title":"J Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/CIRCULATIONAHA.108.792135","article-title":"Some of the people, some of the time: susceptibility to acute rheumatic fever","volume":"119","author":"Bryant","year":"2009","journal-title":"Circulation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"14946","DOI":"10.1038\/ncomms14946","article-title":"Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania","volume":"8","author":"Parks","year":"2017","journal-title":"Nat Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/08830185.2014.917411","article-title":"Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection","volume":"33","author":"Cunningham","year":"2014","journal-title":"Int Rev Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1172\/JCI7132","article-title":"Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin","volume":"106","author":"Galvin","year":"2000","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm892","article-title":"Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea","volume":"9","author":"Kirvan","year":"2003","journal-title":"Nat Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"14579","DOI":"10.1074\/jbc.M414066200","article-title":"Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils","volume":"280","author":"Kneass","year":"2005","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-9255-8-22","article-title":"Role of IL-33 in inflammation and disease","volume":"8","author":"Miller","year":"2011","journal-title":"J Inflamm (Lond)."},{"key":"B39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrcardio.2012.197","article-title":"Revisiting the pathogenesis of rheumatic fever and carditis","volume":"10","author":"Tandon","year":"2013","journal-title":"Nat Rev Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0008-6363(00)00037-7","article-title":"Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart","volume":"46","author":"Kupfahl","year":"2000","journal-title":"Cardiovasc Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI14190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J Clin Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/cancers11101618","article-title":"A comprehensive review on MAPK: a promising therapeutic target in cancer","volume":"11","author":"Braicu","year":"2019","journal-title":"Cancers."},{"key":"B43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2015.00149","article-title":"Extracellular signal-regulated kinases 1 \/ 2 as regulators of cardiac hypertrophy","volume":"6","author":"Kehat","year":"2015"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4161\/cc.8.8.8147","article-title":"How ERK1\/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?","volume":"8","author":"Mebratu","year":"2009","journal-title":"Cell Cycle."},{"key":"B46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nsmb.1418","article-title":"Membrane-dependent signal integration by the Ras activator Son of sevenless","volume":"15","author":"Gureasko","year":"2008","journal-title":"Nat Struct Mol Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","article-title":"Integrating signals from RTKs to ERK\/MAPK","volume":"26","author":"McKay","year":"2007","journal-title":"Oncogene."},{"key":"B49","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbapap.2009.11.002","article-title":"c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges","volume":"1804","author":"Bogoyevitch","year":"2010","journal-title":"Biochim Biophys Acta."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3389\/fimmu.2018.01849","article-title":"Tumor necrosis factor receptor-associated factor regulation of nuclear factor \u03baB and mitogen-activated protein kinase pathways","volume":"9","author":"Shi","year":"2018","journal-title":"Front Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"289243","DOI":"10.1155\/2012\/289243","article-title":"The roles of mitogen-activated protein kinase pathways in TGF-\u03b2-induced epithelial-mesenchymal transition","volume":"2012","author":"Gui","year":"2012","journal-title":"J Signal Transduct."},{"key":"B52","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s0092-8674(03)00432-x","article-title":"Mechanisms of TGF-? signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003"},{"key":"B55","doi-asserted-by":"crossref","first-page":"A5350","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A5350","article-title":"Sustained SMAD2 phosphorylation is required for myofibroblast transformation in response to TGF-beta","volume-title":"C62. FIBROBLAST BIOLOGY American Thoracic Society International Conference Abstracts","author":"Dulin","year":"2019"},{"key":"B56","first-page":"10161","article-title":"Smad2 and Smad3 play differential roles in the regulation of matrix deposition-related enzymes in renal mesangial cells","volume":"10","author":"Yao","year":"2017","journal-title":"Int J Clin Exp Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1039\/C0MB00016G","article-title":"Proteomics of Smad4 regulated transforming growth factor-beta signalling in colon cancer cells","volume":"6","author":"Ali","year":"2010","journal-title":"Mol Biosyst."},{"key":"B58","doi-asserted-by":"publisher","first-page":"a022137","DOI":"10.1101\/cshperspect.a022137","article-title":"Signaling Cross Talk between TGF-\u03b2\/Smad","volume":"9","author":"Luo","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drug Discov."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0156315","article-title":"ST2L transmembrane receptor expression: an immunochemical study on endarterectomy samples","volume":"11","author":"Marzullo","year":"2016","journal-title":"PLoS ONE."},{"key":"B61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12265-013-9459-y","article-title":"ST2 as a cardiovascular risk biomarker: from the bench to the bedside","volume":"6","author":"L Januzzi","year":"2013","journal-title":"J Cardiovasc Transl Res."},{"key":"B62","unstructured":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines47990\n            SchmitzJ\n            OwyangA\n            OldhamE\n            SongY\n            MurphyE\n            McClanahanTK\n          Immunity.232005"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1161\/ATVBAHA.112.300497","article-title":"Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia","volume":"32","author":"Caporali","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"Li","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23937\/2378-3656\/1410255","article-title":"Soluble ST2 - a potential biomarker of rheumatic heart disease","volume":"6","author":"Ramona","year":"2019","journal-title":"Clin Med Rev Case Rep."},{"key":"B66","first-page":"234","article-title":"Valvular heart diseases in the developing world: developmental biology takes center stage","volume":"21","author":"Howell","year":"2012","journal-title":"J Heart Valve Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e76289","DOI":"10.1371\/journal.pone.0076289","article-title":"Angiotensin II facilitates fibrogenic effect of TGF- b 1 through enhancing the down-regulation of BAMBI caused by LPS : a new pro-fibrotic mechanism of angiotensin II","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE."},{"key":"B68","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/cvr\/cvt258","article-title":"Inhibition of Toll-Like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation","volume":"101","author":"Wang","year":"2013","journal-title":"Cardiovasc Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00109-014-1211-9","article-title":"Angiotensin II stimulates canonical TGF-\u03b2 signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction","volume":"93","author":"Ehanire","year":"2015","journal-title":"J Mol Med (Berl)."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1681\/ASN.2016101066","article-title":"Immunologic effects of the renin-angiotensin system","volume":"28","author":"Crowley","year":"2017","journal-title":"JASN"},{"key":"B72","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/1470320312474854","article-title":"Different cross-talk sites between the renin \u2013 angiotensin and the kallikrein \u2013 kinin systems","volume":"15","author":"Su","year":"2014","journal-title":"Angiotensin Aldosterone Syst."},{"key":"B73","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1210\/en.2009-1237","article-title":"Multiple cross talk between angiotensin II, bradykinin, and insulin signaling in the cortical thick ascending limb of rat kidney","volume":"151","author":"Hus-Citharel","year":"2010","journal-title":"Endocrinology."},{"key":"B74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/ijpvm.IJPVM_322_16","article-title":"Effect of angiotensin-converting enzyme inhibitor on cardiac fibrosis and oxidative stress status in lipopolysaccharide-induced inflammation model in rats","volume":"8","author":"Abareshi","year":"2017","journal-title":"Int J Prev Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1523-1755.2004.00462.x","article-title":"An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis","volume":"65","author":"De Albuquerque","year":"2004","journal-title":"Kidney Int."},{"key":"B76","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1096\/fasebj.2018.32.1_supplement.867.4","article-title":"Transient ACE-inhibitor treatment produces persistent change in cardiac fibroblast physiology","volume":"32","author":"Perez","year":"2018","journal-title":"FASEB J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.24293\/ijcpml.v26i1.1366","article-title":"The difference between st2 and nt-pro bnp concentrations before and after-treatment of ace-inhibitors in nyha iii-iv heart failure patients","volume":"26","author":"Maskito","year":"2019","journal-title":"Indones J Clin Pathol Med Lab."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1111\/bph.14489","article-title":"Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-\u03b2-activated kinase 1 (TAK1) pathways in mice","volume":"175","author":"Tan","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"14948","DOI":"10.1073\/pnas.0903958106","article-title":"Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity","volume":"106","author":"Platten","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/sj.bjp.0707454","article-title":"Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats","volume":"152","author":"Dai","year":"2008","journal-title":"Br J Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/s0006-291x(02)00855-0","article-title":"Activation and suppression of renin-angiotensin system in human dendritic cells","volume":"296","author":"Lapteva","year":"2002","journal-title":"Biochem Biophys Res Commun."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/S0002-9440(10)64445-8","article-title":"Immunosuppressive treatment protects against angiotensin II-induced renal damage","volume":"161","author":"Muller","year":"2002","journal-title":"Am J Pathol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1096\/fj.02-0755fje","article-title":"Control of dendritic cell differentiation by angiotensin II","volume":"17","author":"Nahmod","year":"2003","journal-title":"FASEB J."},{"key":"B84","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front Immunol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2020.00115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T05:52:23Z","timestamp":1595915543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2020.00115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":84,"alternative-id":["10.3389\/fcvm.2020.00115"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.00115","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"article-number":"115"}}